Certain drugs that are presently used as treatment options for cancer can prove effective when it comes to minimizing the tissue inflammation level.

This finding was disclosed by scientists at the University of Edinburgh as part of a study that was published in Nature Medicine journal.

From News-Medical.Net:

Professor Chris Haslett, Head of the Queen’s Medical Research Institute at the University of Edinburgh, expects the study to lead to trials of these drugs in human inflammatory diseases. Professors Adriano Rossi and Haslett, who have led this new study with other colleagues from the QMRI, said: “This study offers new hope for patients with severe inflammatory diseases. Specific treatment for such conditions is poor, and the use of steroids is fraught with potential difficulties. We have adopted a different strategy by using non-biological treatments, but this study needs urgently to be translated into trials and we are now seeking major funding to research further how these drugs work.”

Lab tests have suggested that some CDK inhibitors, like Roscovitine, can be effective treatment options for relieving pain and providing relief to patients with lung and joint diseases by reducing the inflammation level in models of rheumatoid arthritis and the fatal ailment called fibrosing alveolitis.

Tags:  cancer treatment, fibrosing alveolitis, Roscovitine, Steroids, tissue inflammation

Posted in  Steroids | No Comments/Questions